Literature DB >> 27485549

Role of frailty and nutritional status in predicting complications following total gastrectomy with D2 lymphadenectomy in patients with gastric cancer: a prospective study.

Fan-Feng Chen1, Fei-Yu Zhang1, Xuan-You Zhou2, Xian Shen3, Zhen Yu4, Cheng-Le Zhuang5,6.   

Abstract

PURPOSE: This study was performed to determine the association of frailty and nutritional status with postoperative complications after total gastrectomy (TG) with D2 lymphadenectomy in patients with gastric cancer.
METHODS: Patients undergoing TG with D2 lymphadenectomy for gastric cancer between August 2014 and February 2016 were enrolled. Frailty was evaluated by sarcopenia which was diagnosed by a combination of third lumbar vertebra muscle index (L3 MI), handgrip strength, and 6-m usual gait speed. Nutritional status was evaluated by the nutritional risk screening 2002 (NRS 2002) score. Univariate and multivariate analyses evaluating the risk factors for postoperative complications were performed.
RESULTS: A total of 158 patients were analyzed, and 27.2 % developed complications within 30 days of surgery. One patient died within 30 days of the operation. In the univariate analyses, NRS 2002 score ≥3 (OR = 2.468, P = 0.012), sarcopenia (OR = 2.764, P = 0.008), and tumor located at the cardia (OR = 2.072, P = 0.046) were associated with the postoperative complications. Multivariable analysis revealed that sarcopenia (OR = 3.084, P = 0.005) and tumor located at the cardia (OR = 2.347, P = 0.026) were independent predictors of postoperative complications.
CONCLUSIONS: This study showed a significant relationship between postoperative complications and geriatric frailty using sarcopenia in patients with gastric cancer after TG with D2 lymphadenectomy. Frailty should be integrated into preoperative risk assessment and may have implications in preoperative decisionmaking.

Entities:  

Keywords:  D2 lymphadenectomy; Frailty; Morbidity; Nutritional status; Sarcopenia; Total gastrectomy

Mesh:

Year:  2016        PMID: 27485549     DOI: 10.1007/s00423-016-1490-4

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  50 in total

1.  Screening of the nutritional risk of patients with gastric carcinoma before operation by NRS 2002 and its relationship with postoperative results.

Authors:  Weiping Guo; Guangsheng Ou; Xi Li; Jianglong Huang; Jiangpei Liu; Hongbo Wei
Journal:  J Gastroenterol Hepatol       Date:  2010-04       Impact factor: 4.029

2.  The impact of sarcopenia on survival and complications in surgical oncology: A review of the current literature.

Authors:  Jeroen L A van Vugt; Stef Levolger; Robert J S Coelen; Ron W F de Bruin; Jan N M IJzermans
Journal:  J Surg Oncol       Date:  2015-10-21       Impact factor: 3.454

3.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

Review 4.  Frailty in the older surgical patient: a review.

Authors:  Judith S L Partridge; Danielle Harari; Jugdeep K Dhesi
Journal:  Age Ageing       Date:  2012-03       Impact factor: 10.668

5.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

6.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

Review 7.  D1 versus D2 lymphadenectomy for gastric cancer.

Authors:  Benjamin Schmidt; Sam S Yoon
Journal:  J Surg Oncol       Date:  2012-04-18       Impact factor: 3.454

8.  Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer.

Authors:  D-D Huang; S-L Wang; C-L Zhuang; B-S Zheng; J-X Lu; F-F Chen; C-J Zhou; X Shen; Z Yu
Journal:  Colorectal Dis       Date:  2015-11       Impact factor: 3.788

9.  Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.

Authors:  Lisa Martin; Laura Birdsell; Neil Macdonald; Tony Reiman; M Thomas Clandinin; Linda J McCargar; Rachel Murphy; Sunita Ghosh; Michael B Sawyer; Vickie E Baracos
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544

10.  Can Sarcopenia Quantified by Ultrasound of the Rectus Femoris Muscle Predict Adverse Outcome of Surgical Intensive Care Unit Patients as well as Frailty? A Prospective, Observational Cohort Study.

Authors:  Noomi Mueller; Sushila Murthy; Christopher R Tainter; Jarone Lee; Kathleen Riddell; Florian J Fintelmann; Stephanie D Grabitz; Fanny P Timm; Benjamin Levi; Tobias Kurth; Matthias Eikermann
Journal:  Ann Surg       Date:  2016-12       Impact factor: 12.969

View more
  11 in total

1.  Sarcopenia related to neoadjuvant chemotherapy and perioperative outcomes in resected gastric cancer: a multi-institutional analysis.

Authors:  Katelin A Mirkin; Franklyn E Luke; Alexandra Gangi; Jose M Pimiento; Daniel Jeong; Christopher S Hollenbeak; Joyce Wong
Journal:  J Gastrointest Oncol       Date:  2017-06

Review 2.  Integration of Geriatric Assessment in the Care of Patients with Gastrointestinal Malignancies.

Authors:  Siri Rostoft
Journal:  Visc Med       Date:  2017-08-03

3.  Predictive Value of Preoperative Sarcopenia in Patients with Gastric Cancer: a Meta-analysis and Systematic Review.

Authors:  Zhengdao Yang; Xin Zhou; Bin Ma; Yanan Xing; Xue Jiang; Zhenning Wang
Journal:  J Gastrointest Surg       Date:  2018-07-09       Impact factor: 3.452

4.  Depletion of skeletal muscle mass adversely affects long-term outcomes for men undergoing gastrectomy for gastric cancer.

Authors:  Katsunobu Sakurai; Naoshi Kubo; Yutaka Tamamori; Naoki Aomatsu; Takafumi Nishii; Akiko Tachimori; Yukio Nishiguchi; Kiyoshi Maeda
Journal:  PLoS One       Date:  2021-08-19       Impact factor: 3.240

Review 5.  Clinical Impact of a Perioperative Exercise Program for Sarcopenia and Overweight/Obesity Gastric Cancer.

Authors:  Toru Aoyama; Masato Nakazono; Shinsuke Nagasawa; Kenki Segami
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 6.  The impact of frailty and sarcopenia on postoperative outcomes in older patients undergoing gastrectomy surgery: a systematic review and meta-analysis.

Authors:  Yanjiao Shen; Qiukui Hao; Jianghua Zhou; Birong Dong
Journal:  BMC Geriatr       Date:  2017-08-21       Impact factor: 3.921

7.  Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer.

Authors:  Carolina Palmela; Sónia Velho; Lisa Agostinho; Francisco Branco; Marta Santos; Maria Pia Costa Santos; Maria Helena Oliveira; João Strecht; Rui Maio; Marília Cravo; Vickie E Baracos
Journal:  J Gastric Cancer       Date:  2017-03-14       Impact factor: 3.720

8.  Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer.

Authors:  Jong Soo Lee; Young Saing Kim; Eun Young Kim; Wook Jin
Journal:  PLoS One       Date:  2018-08-20       Impact factor: 3.240

9.  CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis.

Authors:  Huaiying Su; Junxian Ruan; Tianfeng Chen; Enyi Lin; Lijing Shi
Journal:  Cancer Imaging       Date:  2019-12-03       Impact factor: 3.909

10.  Impact of preoperative muscle quality on postoperative severe complications after radical gastrectomy for gastric cancer patients.

Authors:  Ryota Matsui; Noriyuki Inaki; Toshikatsu Tsuji
Journal:  Ann Gastroenterol Surg       Date:  2021-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.